Just a few months after it closed a Santa Barbara facility, Botox-maker Allergan re-entered the Tri-Counties, agreeing to buy Kythera Biopharmaceuticals Inc. for about $2.1 billion. The deal will add the Westlake Village-based Kythera’s treatments for double chins and male pattern baldness to Allergan’s existing line of products, including a breast-implant operation formerly based on…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
